Welcome!
Home Hyphens Pharma International
Broker's Calls
CGS-CIMB maintains ‘add’ on Hyphens Pharma at lowered target price
Hyphens' gross profit margin showed a 4.8% y-o-y decline to 35.4% in 3QFY2023, which it attributes to inflationary cost pressures.
November 28, 2023
Results
Hyphens Pharma earnings down 47.2% y-o-y in 3QFY2023
Hyphen Pharma's 3QFY2023 earnings of $2.1 million shrank from $4.0 million in the same period last year.
November 09, 2023
Billion Dollar Club 2023
Riverstone focuses on cleanrooms; Hyphens Pharma rides dual growth
Riverstone cautions that the market for healthcare gloves might see consolidation in the coming years because of overcapacity.
November 09, 2023
Broker's Calls
Brokers' Digest: Suntec REIT, Tiong Woon, MLT, Keppel DC REIT, ComfortDelGro, Hyphens Pharma, Frencken
See what the analysts have to say this week.
October 27, 2023
Company in the news
Hyphens Pharma to acquire remaining 58% of shares in Ardence Pharma, making it a wholly-owned subsidiary
Hyphens Pharma sees the acquisition as a way to strengthen its Malaysian presence, first tranche worth $1.86 million.
October 17, 2023
Results
Hyphens Pharma reports two times surge in 2HFY2022 earnings of $5.2 mil
A first and final dividend of 1.11 cents has been proposed for the period, up from FY2021’s dividend of 0.67 cents.
February 28, 2023
Company in the news
Hyphens Pharma licenses topical drug for acne across all Southeast Asia
Hyphens Pharma called the drug a “game-changer” for acne sufferers as it is so far the only topical cream to treat hormonal acne.
December 21, 2022
Broker's Calls
After record 3QFY2022, CGS-CIMB lifts TP, EPS and dividend forecasts on Hyphens Pharma
Hyphens Pharma reported an almost threefold y-o-y jump in its 3QFY2022 profit after tax to $4.0 million.
November 25, 2022
Broker's Calls
'Add' Hyphens Pharma as it moves on to its next phase of growth
CGS-CIMB Research is betting on Hyphens Pharma's next phase of growth.
August 18, 2022
Broker's Calls
Broker's Digest: Silverlake Axis, Hyphens Pharma International, Yangzijiang Financial Holding, ST Engineering
See what the analysts have to say this week.
June 10, 2022